 |
Trials |
Randomised phase II trial on primary chemotherapy with high-dose methtrexate and high-dose cytarabine with or without thiotepa, and with or without rituximab, followed by brain irradiation vs. high-dose chemotherapy supported by autologous stem cell transCancer type: Lymphoma Phase: II Principal Investigator: Pulczynski Elisa Jacobsen Country: DK Keywords: Denmark, Aarhus Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01011920?term=ielsg32&rank=1 |